Publication | Open Access

Heterogeneity of CD8+ tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategies

Prognostic BiomarkersCancer ImmunosurveillanceNon-small-cell Lung CancerMedicineImmunologyPathologyBronchial NeoplasmImmune Checkpoint InhibitorDifferent Sampling StrategiesLung CancerImmunotherapyOncologyTumor MicroenvironmentCd8+ Tumor-infiltrating Lymphocytes